The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A
- PMID: 8489340
The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A
Abstract
A commercially available enzyme immunoassay (EIA) for the detection of Clostridium difficile toxin A (Premier Toxin A EIA, Meridian Diagnostics, Cincinnati, Ohio) was compared with tissue culture cytotoxicity assay, enterotoxigenic culture, and latex agglutination test for the laboratory diagnosis of C difficile-associated disease. When evaluated for detection of C difficile-associated disease using clinical specimens, EIA was the most sensitive (83.1%) and tissue culture cytotoxicity assay was the most specific test with EIA, tissue culture cytotoxicity assay and enterotoxigenic culture having similar correlation values (96.6, 96.1, 94.0%, respectively). The latex agglutination test was not as accurate (89.7% correlation) as the other three tests due mainly to its poor sensitivity (47.9%). The EIA is a rapid, easy-to-use alternative to tissue culture cytotoxicity assay for detection of C difficile-associated disease.
Similar articles
-
Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).Z Gastroenterol. 1998 Feb;36(2):143-9. Z Gastroenterol. 1998. PMID: 9544497
-
Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.Clin Lab Sci. 2009 Spring;22(2):81-5. Clin Lab Sci. 2009. PMID: 19534439
-
Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.Scand J Infect Dis. 2012 Aug;44(8):578-85. doi: 10.3109/00365548.2012.655772. Epub 2012 Mar 11. Scand J Infect Dis. 2012. PMID: 22404319
-
Clostridium difficile testing algorithms: what is practical and feasible?Anaerobe. 2009 Dec;15(6):270-3. doi: 10.1016/j.anaerobe.2009.10.005. Epub 2009 Oct 22. Anaerobe. 2009. PMID: 19853666 Review.
-
Clostridium difficile colitis--diagnosis and therapy.Rocz Akad Med Bialymst. 1996;41(2):176-82. Rocz Akad Med Bialymst. 1996. PMID: 9020528 Review.
Cited by
-
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.J Clin Microbiol. 1996 Nov;34(11):2718-21. doi: 10.1128/jcm.34.11.2718-2721.1996. J Clin Microbiol. 1996. PMID: 8897171 Free PMC article.
-
Biographical Feature: Peter H. Gilligan, Ph.D., D(ABMM), F(AAM).J Clin Microbiol. 2019 Jan 30;57(2):e01872-18. doi: 10.1128/JCM.01872-18. Print 2019 Feb. J Clin Microbiol. 2019. PMID: 30541940 Free PMC article. No abstract available.
-
Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases.J Clin Microbiol. 1993 Nov;31(11):2861-5. doi: 10.1128/jcm.31.11.2861-2865.1993. J Clin Microbiol. 1993. PMID: 8263168 Free PMC article.
-
Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A.J Clin Pathol. 1997 Dec;50(12):996-1000. doi: 10.1136/jcp.50.12.996. J Clin Pathol. 1997. PMID: 9516880 Free PMC article.